Literature DB >> 8402618

Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis.

G Zauli1, D Gibellini, D Milani, M Mazzoni, P Borgatti, M La Placa, S Capitani.   

Abstract

We report here that the tat gene product of human immunodeficiency virus type 1 was able to protect lymphoblastoid (Jurkat), epithelial (293) and neuronal (PC12) cell lines from apoptotic death induced by serum withdrawal. The rescue from apoptosis by Tat was reflected by an increased expression of Bcl-2 protein in tat-positive Jurkat cells with respect to mock-transfected Jurkat cells after 3-6 days of serum-free cultures. We propose that the ability of the regulatory human immunodeficiency virus type 1 Tat protein to suppress apoptosis might have important implications in understanding the pathogenesis of frequent neoplastic disorders observed in human immunodeficiency virus type 1-seropositive individuals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8402618

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

1.  Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus.

Authors:  B Etemad-Moghadam; D Rhone; T Steenbeke; Y Sun; J Manola; R Gelman; J W Fanton; P Racz; K Tenner-Racz; M K Axthelm; N L Letvin; J Sodroski
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Enhancement of chemical hepatocarcinogenesis by the HIV-1 tat gene.

Authors:  G Altavilla; A Caputo; M Lanfredi; C Piola; G Barbanti-Brodano; A Corallini
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 3.  Lymphoid leukosis viruses, their recognition as 'persistent' viruses and comparisons with certain other retroviruses of veterinary importance.

Authors:  C Darcel
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

4.  Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infection.

Authors:  Ruth H Florese; Roger W Wiseman; David Venzon; Julie A Karl; Thorsten Demberg; Kay Larsen; Leon Flanary; V S Kalyanaraman; Ranajit Pal; Fausto Titti; L Jean Patterson; Megan J Heath; David H O'Connor; Aurelio Cafaro; Barbara Ensoli; Marjorie Robert-Guroff
Journal:  Vaccine       Date:  2008-04-30       Impact factor: 3.641

Review 5.  Role of the Fas/Fas ligand apoptotic pathway in human immunodeficiency virus type 1 disease.

Authors:  D Kaplan; S Sieg
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

6.  Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1.

Authors:  F Demarchi; F d'Adda di Fagagna; A Falaschi; M Giacca
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

Review 7.  Genetic variation and function of the HIV-1 Tat protein.

Authors:  Cassandra Spector; Anthony R Mele; Brian Wigdahl; Michael R Nonnemacher
Journal:  Med Microbiol Immunol       Date:  2019-03-05       Impact factor: 3.402

Review 8.  Doxycycline-inducible and astrocyte-specific HIV-1 Tat transgenic mice (iTat) as an HIV/neuroAIDS model.

Authors:  Dianne Langford; Byung Oh Kim; Wei Zou; Yan Fan; Pejman Rahimain; Ying Liu; Johnny J He
Journal:  J Neurovirol       Date:  2017-11-15       Impact factor: 2.643

9.  Open reading frame 5 of porcine reproductive and respiratory syndrome virus as a cause of virus-induced apoptosis.

Authors:  P Suárez; M Díaz-Guerra; C Prieto; M Esteban; J M Castro; A Nieto; J Ortín
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

10.  Immunihistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi's sarcoma.

Authors:  C B Morris; R Gendelman; A J Marrogi; M Lu; J M Lockyer; W Alperin-Lea; B Ensoli
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.